HUB Organoids Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 71

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $129M

HUB Organoids General Information

Description

Operator of a biotechnology research company intended to develop patient-derived mini-organs from both healthy and diseased tissues. The company specializes in drug discovery and development, preclinical patient stratification, predictive diagnostics, personalized medicine, clinical trials, regenerative medicine, and companion diagnostics, and licenses its proprietary technology and provides services and access to its living organoid biobanks, enabling biotechnology businesses to obtain all these services in one place.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Yalelaan 62
  • 3584 CM Utrecht
  • Netherlands
+31 088
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Parent Company
Corporate Office
  • Yalelaan 62
  • 3584 CM Utrecht
  • Netherlands
+31 088

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HUB Organoids Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 23-Dec-2024 $129M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
To view HUB Organoids’s complete valuation and funding history, request access »

HUB Organoids Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology research company intended to develop patient-derived mini-organs from both healthy and disea
Other Pharmaceuticals and Biotechnology
Utrecht, Netherlands
71 As of 2025

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HUB Organoids Competitors (1)

One of HUB Organoids’s competitors is Oisin Biotechnologies, a Venture Capital-Backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oisin Biotechnologies Venture Capital-Backed Seattle, WA
You’re viewing 1 of 1 competitors. Get the full list »

HUB Organoids Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HUB Organoids Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
LifeSciences@Work Accelerator/Incubator
To view HUB Organoids’s complete investors history, request access »

HUB Organoids FAQs

  • When was HUB Organoids founded?

    HUB Organoids was founded in 2013.

  • Where is HUB Organoids headquartered?

    HUB Organoids is headquartered in Utrecht, Netherlands.

  • What is the size of HUB Organoids?

    HUB Organoids has 71 total employees.

  • What industry is HUB Organoids in?

    HUB Organoids’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is HUB Organoids a private or public company?

    HUB Organoids is a Private company.

  • What is the current valuation of HUB Organoids?

    The current valuation of HUB Organoids is .

  • What is HUB Organoids’s current revenue?

    The current revenue for HUB Organoids is .

  • Who are HUB Organoids’s investors?

    LifeSciences@Work has invested in HUB Organoids.

  • Who are HUB Organoids’s competitors?

    Oisin Biotechnologies is a competitor of HUB Organoids.

  • When was HUB Organoids acquired?

    HUB Organoids was acquired on 23-Dec-2024.

  • Who acquired HUB Organoids?

    HUB Organoids was acquired by Merck.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process